|Articles|July 1, 2015
Addressing Drug Quality: Aging Facilities
Sue Schniepp, Chair, PDA Regulatory and Quality Advisory Board, and Hal Basemen, Chair, PDA, speak with BioPharm International.
Advertisement
Sue Schniepp, Chair, PDA Regulatory and Quality Advisory Board, and Hal Basemen, Chair, PDA, spoke with BioPharm International about addressing drug quality in aging facilities.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
